| 000 | 01290 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517221452.0 | ||
| 264 | 0 | _c20191108 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a1399-0012 | ||
| 024 | 7 |
_a10.1111/ctr.13306 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHendijani, Fatemeh | |
| 245 | 0 | 0 |
_aEffect of CYP3A5*1 expression on tacrolimus required dose after liver transplantation: A systematic review and meta-analysis. _h[electronic resource] |
| 260 |
_bClinical transplantation _c08 2018 |
||
| 300 |
_ae13306 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review | ||
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGraft Rejection _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver Transplantation _xmethods |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 700 | 1 | _aAzarpira, Negar | |
| 700 | 1 | _aKaviani, Maryam | |
| 773 | 0 |
_tClinical transplantation _gvol. 32 _gno. 8 _gp. e13306 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ctr.13306 _zAvailable from publisher's website |
| 999 |
_c28483753 _d28483753 |
||